Eli Lilly (LLY) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$108.3 million.
- Eli Lilly's Non Operating Income rose 199.1% to -$108.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$571.0 million, marking a year-over-year decrease of 16073.06%. This contributed to the annual value of -$571.0 million for FY2025, which is 16073.06% down from last year.
- Per Eli Lilly's latest filing, its Non Operating Income stood at -$108.3 million for Q4 2025, which was up 199.1% from -$133.1 million recorded in Q3 2025.
- Eli Lilly's Non Operating Income's 5-year high stood at $321.1 million during Q1 2021, with a 5-year trough of -$635.9 million in Q3 2021.
- In the last 5 years, Eli Lilly's Non Operating Income had a median value of -$84.0 million in 2021 and averaged -$60.8 million.
- Its Non Operating Income has fluctuated over the past 5 years, first surged by 43635.19% in 2022, then crashed by 98191.88% in 2025.
- Over the past 5 years, Eli Lilly's Non Operating Income (Quarter) stood at -$77.3 million in 2021, then surged by 436.35% to $260.0 million in 2022, then crashed by 53.35% to $121.3 million in 2023, then plummeted by 191.1% to -$110.5 million in 2024, then grew by 1.99% to -$108.3 million in 2025.
- Its Non Operating Income stands at -$108.3 million for Q4 2025, versus -$133.1 million for Q3 2025 and -$90.6 million for Q2 2025.